Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 249
Filtrar
1.
Br J Dermatol ; 184(1): 141-150, 2021 01.
Artigo em Inglês | MEDLINE | ID: mdl-32779733

RESUMO

BACKGROUND: There are two distinctive acral manifestations of COVID-19 embodying disparate clinical phenotypes. One is perniosis occurring in mildly symptomatic patients, typically children and young adults; the second is the thrombotic retiform purpura of critically ill adults with COVID-19. OBJECTIVES: To compare the clinical and pathological profiles of these two different cutaneous manifestations of COVID-19. METHODS: We compared the light microscopic, phenotypic, cytokine and SARS-CoV-2 protein and RNA profiles of COVID-19-associated perniosis with that of thrombotic retiform purpura in critical patients with COVID-19. RESULTS: Biopsies of COVID-19-associated perniosis exhibited vasocentric and eccrinotropic T-cell- and monocyte-derived CD11c+ , CD14+ and CD123+ dendritic cell infiltrates. Both COVID-associated and idiopathic perniosis showed striking expression of the type I interferon-inducible myxovirus resistance protein A (MXA), an established marker for type I interferon signalling in tissue. SARS-CoV-2 RNA, interleukin-6 and caspase 3 were minimally expressed and confined to mononuclear inflammatory cells. The biopsies from livedo/retiform purpura showed pauci-inflammatory vascular thrombosis without any MXA decoration. Blood vessels exhibited extensive complement deposition with endothelial cell localization of SARS-CoV-2 protein, interleukin-6 and caspase 3; SARS-CoV-2 RNA was not seen. CONCLUSIONS: COVID-19-associated perniosis represents a virally triggered exaggerated immune reaction with significant type I interferon signaling. This is important to SARS-CoV-2 eradication and has implications in regards to a more generalized highly inflammatory response. We hypothesize that in the thrombotic retiform purpura of critically ill patients with COVID-19, the vascular thrombosis in the skin and other organ systems is associated with a minimal interferon response. This allows excessive viral replication with release of viral proteins that localize to extrapulmonary endothelium and trigger extensive complement activation.


Assuntos
COVID-19/complicações , Pérnio/diagnóstico , Livedo Reticular/diagnóstico , Púrpura/diagnóstico , SARS-CoV-2/imunologia , Adolescente , Fatores Etários , Idoso , Biópsia , COVID-19/diagnóstico , COVID-19/imunologia , COVID-19/virologia , Caspase 3/imunologia , Caspase 3/metabolismo , Pérnio/imunologia , Pérnio/patologia , Diagnóstico Diferencial , Feminino , , Mãos , Humanos , Interferon Tipo I/imunologia , Interferon Tipo I/metabolismo , Interleucina-6/imunologia , Interleucina-6/metabolismo , Livedo Reticular/imunologia , Livedo Reticular/patologia , Livedo Reticular/virologia , Masculino , Pessoa de Meia-Idade , Proteínas de Resistência a Myxovirus/análise , Proteínas de Resistência a Myxovirus/metabolismo , Púrpura/imunologia , Púrpura/patologia , Púrpura/virologia , RNA Viral/isolamento & purificação , SARS-CoV-2/genética , SARS-CoV-2/isolamento & purificação , Índice de Gravidade de Doença , Pele/imunologia , Pele/patologia , Pele/virologia , Glicoproteína da Espícula de Coronavírus/imunologia , Glicoproteína da Espícula de Coronavírus/isolamento & purificação
6.
J Cutan Pathol ; 46(7): 542-545, 2019 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-30957244

RESUMO

Lymphomatoid papulosis (LyP) type E is a recently described variant characterized by the occurrence of large necrotic eschar-like lesions displaying microscopically angioinvasive and angiodestructive infiltrates of CD30+ lymphocytes, frequently coexpressing CD8. Rare cases of LyP type E with a CD56+ immunophenotype have been described. Herein, we describe a 36-year-old woman with LyP type E, characterized by purpura-like lesions on her left ankle. Initially, she presented with left ankle swelling, petechiae and ecchymosis, and rapidly developing necrotic papules, all of which resolved spontaneously over a period of a few months without intentional therapy. Biopsy revealed CD30 and CD56 positive atypical cell infiltrates with marked angiocentricity and angiodestruction. Awareness of this rare LyP variant and its correct recognition, even if the clinical presentation is unusual, is important to avoid aggressive treatment.


Assuntos
Antígeno CD56 , Papulose Linfomatoide , Proteínas de Neoplasias , Púrpura , Neoplasias Cutâneas , Adulto , Antígeno CD56/imunologia , Antígeno CD56/metabolismo , Feminino , Humanos , Imunofenotipagem , Papulose Linfomatoide/imunologia , Papulose Linfomatoide/metabolismo , Papulose Linfomatoide/patologia , Proteínas de Neoplasias/imunologia , Proteínas de Neoplasias/metabolismo , Púrpura/imunologia , Púrpura/metabolismo , Púrpura/patologia , Neoplasias Cutâneas/imunologia , Neoplasias Cutâneas/metabolismo , Neoplasias Cutâneas/patologia
7.
J Clin Rheumatol ; 25(3): e16-e26, 2019 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-29782427

RESUMO

OBJECTIVES: The aims of this study were to describe clinical and laboratory manifestations of patients with levamisole-adulterated cocaine-induced vasculitis/vasculopathy and to propose a skin classification according to the distribution and severity of lesions. METHODS: We report the characteristics of 30 patients admitted with levamisole-adulterated cocaine-induced vasculitis/vasculopathy in 4 high-complexity institutions in Colombia, from December 2010 to May 2017. We compare our findings with the main published series. RESULTS: Median age was 31 years (interquartile range, 27-38 years) with a male-to-female ratio of 5:1. Eighty-three percent of the patients had retiform purpura affecting the limbs, buttocks, face, or abdomen; 73% had ear necrosis, 50% cutaneous ulcers, 17% genital necrosis, 13% oral ulcers, and 10% digital necrosis. Cutaneous involvement was classified according to the frequency of the compromised corporal area, and purpuric lesions were stratified in 4 grades of severity. Anti-neutrophil cytoplasmic autoantibodies were positive in 85% of the cases, lupus anticoagulant in 73%, and antinuclear autoantibodies in 57%; rheumatoid factor was negative in all cases. We found nephritis in 17 cases (57%). Prednisolone was used in most of the patients (70%), with other immunosuppressive agents being used in a lower percentage. Improvement was observed in 93% of the patients, but symptoms recurred in 40%, attributed to relapses in consumption. End-stage chronic renal disease developed in 10% of the cases, and 1 patient died. CONCLUSIONS: Because of rising cocaine consumption and levamisole adulteration frequency, levamisole-adulterated cocaine-induced vasculitis/vasculopathy is becoming more common. Detailed characterization of skin involvement coupled with multiple antibody positivity is essential for a diagnosis. Renal involvement is frequent, clinically and histologically heterogeneous, and potentially serious.


Assuntos
Transtornos Relacionados ao Uso de Cocaína/complicações , Cocaína , Glomerulonefrite , Levamisol , Púrpura , Vasculite , Adjuvantes Farmacêuticos/efeitos adversos , Adjuvantes Farmacêuticos/farmacologia , Adulto , Autoanticorpos/sangue , Cocaína/farmacologia , Colômbia , Inibidores da Captação de Dopamina/farmacologia , Contaminação de Medicamentos , Feminino , Glomerulonefrite/induzido quimicamente , Glomerulonefrite/diagnóstico , Glomerulonefrite/imunologia , Glomerulonefrite/terapia , Humanos , Levamisol/efeitos adversos , Levamisol/farmacologia , Masculino , Necrose , Administração dos Cuidados ao Paciente/métodos , Púrpura/induzido quimicamente , Púrpura/diagnóstico , Púrpura/imunologia , Púrpura/terapia , Pele/patologia , Resultado do Tratamento , Vasculite/induzido quimicamente , Vasculite/diagnóstico , Vasculite/imunologia , Vasculite/terapia
8.
Rev Chilena Infectol ; 35(4): 445-447, 2018 Aug.
Artigo em Espanhol | MEDLINE | ID: mdl-30534933

RESUMO

Infection with Strongyloides stercoralis is a common parasitic infection in tropical and subtropical regions, including the Peruvian Amazon. The clinical manifestations are varied in patients with immunocompromised disease, and the systemic spread of the disease is frequent, compromising different organs and systems. Cutaneous manifestations are infrequent, being described in patients with some degree of immunosuppression. We present the case of an immunocompetent patient who developed a reactive purpura due to chronic Strongyloides stercoralis infection. Thus, skin involvement is possible in immunocompetent patients with systemic exacerbation due to this parasite.


Assuntos
Púrpura/etiologia , Púrpura/imunologia , Estrongiloidíase/complicações , Estrongiloidíase/imunologia , Adulto , Animais , Antiparasitários/classificação , Antiparasitários/uso terapêutico , Antipruriginosos/uso terapêutico , Clorfeniramina/uso terapêutico , Humanos , Hospedeiro Imunocomprometido , Ivermectina/uso terapêutico , Masculino , Púrpura/tratamento farmacológico , Strongyloides stercoralis/isolamento & purificação , Adulto Jovem
9.
Rev. chil. infectol ; 35(4): 445-447, ago. 2018. graf
Artigo em Espanhol | LILACS | ID: biblio-978056

RESUMO

Resumen La infección por Strongyloides stercoralis es una parasitosis frecuente en las regiones tropicales y subtropicales, incluyendo la Amazonía peruana. En pacientes con inmunocompromiso, las manifestaciones clínicas son variadas y es frecuente la diseminación sistémica de la enfermedad, con compromiso de diversos órganos. Las manifestaciones cutáneas son infrecuentes y se describen en pacientes con algún grado de inmunosupresión. Se presenta el caso de un paciente inmunocompetente que desarrolló una púrpura reactiva por una infección por Strongyloides stercoralis crónica. Ante ello, es posible el compromiso cutáneo en pacientes inmunocompetentes con reagudización sistémica por este parásito.


Infection with Strongyloides stercoralis is a common parasitic infection in tropical and subtropical regions, including the Peruvian Amazon. The clinical manifestations are varied in patients with immunocompromised disease, and the systemic spread of the disease is frequent, compromising different organs and systems. Cutaneous manifestations are infrequent, being described in patients with some degree of immunosuppression. We present the case of an immunocompetent patient who developed a reactive purpura due to chronic Strongyloides stercoralis infection. Thus, skin involvement is possible in immunocompetent patients with systemic exacerbation due to this parasite.


Assuntos
Humanos , Animais , Masculino , Adulto , Adulto Jovem , Púrpura/etiologia , Púrpura/imunologia , Estrongiloidíase/complicações , Estrongiloidíase/imunologia , Púrpura/tratamento farmacológico , Ivermectina/uso terapêutico , Clorfeniramina/uso terapêutico , Hospedeiro Imunocomprometido , Strongyloides stercoralis/isolamento & purificação , Antiparasitários/classificação , Antiparasitários/uso terapêutico , Antipruriginosos/uso terapêutico
10.
Clin Lab ; 64(4): 615-618, 2018 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-29739081

RESUMO

BACKGROUND: While different clinical manifestations of IgM and IgG monoclonal cryoglobulins have been demonstrated, little is known about the roles of IgG subclasses in the pathophysiology of these conditions. METHODS: In two cases of myeloma-associated monoclonal (type I) cryoglobulinemia with quite distinct clinical and biological features, serum samples were analyzed using an original IgG subclass-specific immunoblotting technique. RESULTS: The first case had painful arthritis of hands and feet, with skin purpura and a sharp decrease of complement C4 level, and the cryoglobulin was of IgG1 subclass. The second case displayed mostly thrombotic lesions of the limb extremities, C3 and C4 serum levels were normal, and the cryoglobulin belonged to the IgG2 subclass. CONCLUSIONS: Type I cryoglobulins of distinct IgG subclasses may result in different syndromes. In both cases, the treatment relies on eradication of the underlying plasma cell dyscrasia.


Assuntos
Crioglobulinas/metabolismo , Imunoglobulina G/sangue , Mieloma Múltiplo/sangue , Paraproteinemias/terapia , Idoso de 80 Anos ou mais , Complemento C4/imunologia , Complemento C4/metabolismo , Crioglobulinas/imunologia , Evolução Fatal , Feminino , Humanos , Imunoglobulina G/imunologia , Imunoglobulina M/sangue , Imunoglobulina M/imunologia , Pessoa de Meia-Idade , Mieloma Múltiplo/diagnóstico , Mieloma Múltiplo/imunologia , Paraproteinemias/diagnóstico , Paraproteinemias/imunologia , Púrpura/sangue , Púrpura/imunologia
12.
Dermatol Online J ; 21(7)2015 Jul 15.
Artigo em Inglês | MEDLINE | ID: mdl-26436970

RESUMO

Antiphospholipid syndrome is an autoimmune disorder characterized by the occurrence of venous and arterial thrombosis, as well as morbidity in pregnancy, in the presence of anti-phospholipid antibodies. The diagnosis of antiphospholipid syndrome is usually established based on clinical and laboratory findings by strictly following the 2006 Sapporo classification. However, the diagnosis remains challenging owing to the ongoing debates on the serological criteria. We report a case we describe as forme fruste antiphospholipid syndrome in which these criteria were not fulfilled. Purpura appeared repeatedly in a female infant starting from the age of 6 months and following episodes of upper respiratory infections and vaccinations. The levels of anti-cardiolipin IgG antibodies and anti-phosphatidylserine/prothrombin complex antibodies were elevated in accordance with these events. Histopathological evaluation revealed multiple small vessel thrombi in the dermis and adipose tissue. After 2 weeks of treatment with aspirin and heparin, the cutaneous symptoms subsided. Infection has long been associated with antiphospholipid syndrome, and anti-phosphatidylserine/prothrombin antibodies are considered a new marker for the diagnosis of antiphospholipid syndrome. Forme fruste antiphospholipid syndrome should be considered even if the antiphospholipid syndrome diagnostic criteria are not completely fulfilled, especially in the presence of elevated levels of anti-phosphatidylserine/prothrombin antibodies and known preceding infections.


Assuntos
Anticorpos Anticardiolipina/imunologia , Síndrome Antifosfolipídica/imunologia , Síndrome Antifosfolipídica/patologia , Fosfatidilserinas/imunologia , Protrombina/imunologia , Anticorpos Anticardiolipina/metabolismo , Síndrome Antifosfolipídica/tratamento farmacológico , Aspirina/uso terapêutico , Autoanticorpos/imunologia , Autoanticorpos/metabolismo , Infecções Bacterianas/imunologia , Infecções Bacterianas/fisiopatologia , Biópsia por Agulha , Pré-Escolar , Progressão da Doença , Feminino , Humanos , Imuno-Histoquímica , Fosfatidilserinas/metabolismo , Prognóstico , Protrombina/metabolismo , Púrpura/imunologia , Púrpura/patologia , Púrpura/fisiopatologia , Recidiva , Medição de Risco , Resultado do Tratamento
13.
BMJ Case Rep ; 20152015 May 02.
Artigo em Inglês | MEDLINE | ID: mdl-25935915

RESUMO

Nitrofurantoin is commonly prescribed to treat urinary tract infections (UTI). Reported adverse effects include gastrointestinal, pulmonary, hepatic and neurological disorders. We report a case of a 67-year-old woman treated for UTI with nitrofurantoin who presented with antineutrophilic cytoplasmic antibody (ANCA)-associated renal and skin vasculitis 3 days after starting treatment. The symptoms resolved following withdrawal of the drug and treatment with steroids. This is the first reported case of nitrofurantoin causing ANCA-associated vasculitis.


Assuntos
Anti-Infecciosos Urinários/efeitos adversos , Vasculite Associada a Anticorpo Anticitoplasma de Neutrófilos/diagnóstico , Anticorpos Anticitoplasma de Neutrófilos/metabolismo , Febre/induzido quimicamente , Nitrofurantoína/efeitos adversos , Púrpura/induzido quimicamente , Infecções Urinárias/tratamento farmacológico , Idoso , Anti-Infecciosos Urinários/administração & dosagem , Vasculite Associada a Anticorpo Anticitoplasma de Neutrófilos/induzido quimicamente , Vasculite Associada a Anticorpo Anticitoplasma de Neutrófilos/tratamento farmacológico , Feminino , Febre/tratamento farmacológico , Febre/imunologia , Humanos , Nitrofurantoína/administração & dosagem , Púrpura/tratamento farmacológico , Púrpura/imunologia , Resultado do Tratamento
15.
Ann Dermatol Venereol ; 141(5): 331-5, 2014 May.
Artigo em Francês | MEDLINE | ID: mdl-24835645

RESUMO

BACKGROUND: Pigmented purpuric dermatosis (or Schamberg's disease) is characterized by chronic macular purpura and capillaritis. It is more common in young adult males and adolescents and is generally localized on the lower limbs. In this article, we report on five young children with generalized Schamberg's disease. PATIENTS AND METHODS: Five children (aged 13 months to 5 years) were included in this retrospective study. Time to consultation delay ranged from 15 days to 1 year. RESULTS: All patients presented asymptomatic generalized macular purpura. Skin biopsies were performed in 4 cases and were characteristic. The results of coagulation tests and complete blood counts were within the normal range in all patients. The clinical course was chronic, with periods of improvement and worsening. No treatment was prescribed. DISCUSSION: Schamberg's disease is uncommon in childhood. Our observations suggest that this diagnosis is not exceptional. Clinical appearance, setting and normal blood count values are sufficient to enable a diagnosis to be made. The clinical course is generally chronic, and as yet no treatments have demonstrated efficacy.


Assuntos
Púrpura/patologia , Pré-Escolar , Progressão da Doença , Feminino , Humanos , Lactente , Masculino , Púrpura/imunologia , Estudos Retrospectivos
16.
Transfus Apher Sci ; 50(2): 189-99, 2014 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-24685245

RESUMO

Genotyping is an important tool in the diagnosis of disorders involving allo-immunisation to antigens present on the membranes of platelets and neutrophils. To date 28 human platelet antigens (HPAs) have been indentified on six polymorphic glycoproteins on the surface of platelets. Antibodies against HPAs play a role in foetal and neonatal alloimmune thrombocytopenia (FNAIT), post-transfusion purpura (PTP) and refractoriness to donor platelets. The 11 human neutrophil antigens (HNAs) described to date have been indentified on five polymorphic proteins on the surface of granulocytes. Antibodies to HNAs are implicated with foetal and neonatal alloimmune neutropenia (FNAIN), autoimmune neutropenia (AIN) and transfusion related acute lung injury (TRALI). In this report, we will review the molecular basis and techniques currently available for the genotyping of human platelet and neutrophil antigens.


Assuntos
Antígenos de Plaquetas Humanas/genética , Plaquetas , Transfusão de Sangue , Técnicas de Genotipagem/métodos , Neutrófilos , Antígenos de Plaquetas Humanas/imunologia , Autoanticorpos/imunologia , Doenças Autoimunes/etiologia , Doenças Autoimunes/genética , Doenças Autoimunes/imunologia , Neutropenia Febril/etiologia , Neutropenia Febril/genética , Neutropenia Febril/imunologia , Feminino , Humanos , Masculino , Púrpura/etiologia , Púrpura/genética , Púrpura/imunologia , Púrpura/prevenção & controle , Trombocitopenia Neonatal Aloimune/genética , Trombocitopenia Neonatal Aloimune/imunologia , Trombocitopenia Neonatal Aloimune/prevenção & controle
18.
Dtsch Med Wochenschr ; 138(16): Seite 1-30, 2013 Apr.
Artigo em Alemão | MEDLINE | ID: mdl-23608886

RESUMO

HISTORY AND ADMISSION FINDINGS: We report on the case of a young women presenting with macrohaematuria, petechiae and strong headaches. INVESTIGATIONS: Laboratory showed a thrombotic microangiopathy with helmet cells, increased LDH levels (>600 U/l), and thrombocytopenia (<40,000/µl). DIAGNOSIS, TREATMENT AND COURSE: Due to strong haemolytic activity and headache with blurred vision, immediate plasma separation with fresh frozen plasma was commenced. Markedly decreased ADAMTS13 activity and detection of anti-ADAMTS13 antibodies were consistent with the diagnosis of idiopathic thrombotic thrombocytopenic purpura. In total, 11 plasma separations were required to stop disease activity. In parallel, immunosuppressive therapy using glucocorticoids was initiated. The patient was discharged from the hospital in a good general condition and with normalized laboratory findings 26 days after hospitalization. CONCLUSIONS: All patients with anemia and thrombocytopenia should be tested for haemolysis and helmet cells. An early diagnosis and initiation of necessary therapy are determining for the clinical outcome.


Assuntos
Hematúria/etiologia , L-Lactato Desidrogenase/sangue , Púrpura Trombocitopênica Trombótica/diagnóstico , Púrpura/etiologia , Trombocitopenia/diagnóstico , Microangiopatias Trombóticas/diagnóstico , Cefaleias Vasculares/etiologia , Proteínas ADAM/imunologia , Proteína ADAMTS13 , Adulto , Membrana Eritrocítica/patologia , Feminino , Glucocorticoides/uso terapêutico , Hematúria/imunologia , Hematúria/terapia , Hemólise , Humanos , Imunossupressores/uso terapêutico , Plasma , Plasmaferese , Púrpura/imunologia , Púrpura/terapia , Púrpura Trombocitopênica Trombótica/imunologia , Púrpura Trombocitopênica Trombótica/terapia , Trombocitopenia/imunologia , Trombocitopenia/terapia , Microangiopatias Trombóticas/imunologia , Microangiopatias Trombóticas/terapia , Cefaleias Vasculares/imunologia , Cefaleias Vasculares/terapia
20.
Semin Arthritis Rheum ; 41(3): 434-44, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21868067

RESUMO

OBJECTIVE: We describe 4 patients who presented with palpable purpura, arthralgia or arthritis, leukopenia, and antineutrophil cytoplasmic antigen (ANCA) positivity most likely as a result of a hypersensitivity reaction to cocaine-levamisole induced vasculopathy. METHODS: Cases were seen and reviewed in both the inpatient consult service and the outpatient clinics at Rhode Island Hospital from August 2009 to August 2010. Clinical characteristics as well as pertinent laboratory parameters were also reviewed and corroborated with a review of the present literature. RESULTS: We describe 3 cases of cocaine-levamisole-related cutaneous vasculitis with or without associated neutropenia, and 1 case of severe neutropenia with oral mucosal ulceration. Further serologic studies revealed maximum titers of ANCA mostly in a perinuclear pattern. Antimyeloperoxidase tested negative or mildly elevated in our cohort. Three patients with neutropenia had positive antigranulocyte IgM antibody. Nonsteroidal anti-inflammatory drugs were effective as first-line treatment for joint pain. The use of colchicine and systemic corticosteroid was employed to manage severe and persistent skin lesions. CONCLUSIONS: Cocaine-levamisole-related cutaneous vasculitis with leukopenia is a diagnosis of exclusion, but this diagnosis should be strongly considered in patients with a history of cocaine abuse who present with a tetrad of cutaneous manifestations consisting of palpable purpura or bullae with ear involvement, arthralgias, leukopenia, and positive ANCA in high titers and negative Antimyeloperoxidase, when other infectious or idiopathic vasculitic entities have been excluded.


Assuntos
Antirreumáticos/efeitos adversos , Cocaína/efeitos adversos , Inibidores da Captação de Dopamina/efeitos adversos , Leucopenia/induzido quimicamente , Levamisol/efeitos adversos , Vasculite Leucocitoclástica Cutânea/induzido quimicamente , Feminino , Humanos , Leucopenia/imunologia , Leucopenia/patologia , Masculino , Pessoa de Meia-Idade , Púrpura/induzido quimicamente , Púrpura/imunologia , Púrpura/patologia , Vasculite Leucocitoclástica Cutânea/imunologia , Vasculite Leucocitoclástica Cutânea/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA